Drug Patents owned by Romeg

1. Drug name - GLOPERBA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10383820 ROMEG Colchicine drug-to-drug interactions
Nov, 2036

(13 years from now)

US10383821 ROMEG Colchicine drug-to-drug interactions
Nov, 2036

(13 years from now)

US9907751 ROMEG Composition and method of use of colchicine oral liquid
Nov, 2036

(13 years from now)

US10226423 ROMEG Colchicine drug-to-drug interactions
Dec, 2037

(15 years from now)

Drugs and Companies using COLCHICINE ingredient

Market Authorisation Date: 30 January, 2019

Treatment: A method of prophylactic treatment of gout flares in adults comprises administering to a patient a liquid colchicine oral solution

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
0.6MG/5ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in